Lipids and Cardiovascular Risk with CKD

被引：14
|
作者：
Afshinnia, Farsad [1 ]
Pennathur, Subramaniam [1 ,2 ]
机构：
[1] Univ Michigan, Dept Internal Med Nephrol, 1000 Wall St, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2020年 / 15卷 / 01期
关键词：
chronic kidney disease; cardiovascular disease; lipids; humans; HDL cholesterol; LDL cholesterol; LDL lipoproteins; IDL lipoproteins; metabolic syndrome; chylomicrons; monocytes; cardiovascular diseases; insulin resistance; carrier proteins; cytokines; cholesterol; triglycerides; VLDL lipoproteins; atherosclerosis; dyslipidemias; apolipoproteins; obesity; macrophages; proteinuria; chronic renal insufficiency; DISEASE;
D O I：
10.2215/CJN.13531119
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5 / 7
页数：3
相关论文
共 50 条
  • [1] Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD
    Lamprea-Montealegre, Julio Alejandro
    Staplin, Natalie
    Herrington, William G.
    Haynes, Richard
    Emberson, Jonathan
    Baigent, Colin
    de Boer, Ian H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (01): : 47 - 60
  • [2] Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD
    Saland, Jeffrey M.
    Kupferman, Juan C.
    Pierce, Christopher B.
    Flynn, Joseph T.
    Mitsnefes, Mark M.
    Warady, Bradley A.
    Furth, Susan L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (12): : 1711 - 1718
  • [3] Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
    Bajaj, Archna
    Xie, Dawei
    Cedillo-Couvert, Esteban
    Charleston, Jeanne
    Chen, Jing
    Deo, Rajat
    Feldman, Harold, I
    Go, Alan S.
    He, Jiang
    Horwitz, Edward
    Kallem, Radhakrishna
    Rahman, Mahboob
    Weir, Matthew R.
    Anderson, Amanda H.
    Rader, Daniel J.
    Appel, Lawrence J.
    Kusek, John W.
    Lash, James P.
    Rao, Panduranga S.
    Townsend, Raymond R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (06) : 827 - 836
  • [4] Neck Circumference as a Predictive Indicator of CKD for High Cardiovascular Risk Patients
    Liu, Ya-Fang
    Chang, Shih-Tai
    Lin, Wei-Shiang
    Hsu, Jen-Te
    Chung, Chang-Min
    Chang, Jung-Jung
    Hung, Kuo-Chun
    Chen, Kang-Hua
    Chang, Chi-Wen
    Chen, Fu-Chi
    Shih, Yun-Wen
    Chu, Chi-Ming
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [5] The role of lipids and uremic toxins in cardiovascular disease in CKD
    Massy, Ziad A.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 255 - 256
  • [6] Cardiovascular Risk Prediction in CKD
    Ballew, Shoshana H.
    Matsushita, Kunihiro
    SEMINARS IN NEPHROLOGY, 2018, 38 (03) : 208 - 216
  • [7] Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population
    Vallee, Alexandre
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA
    Sinari, Shripad
    Koska, Juraj
    Hu, Yueming
    Furtado, Jeremy
    Jensen, Majken K.
    Budoff, Matthew J.
    Nedelkov, Dobrin
    McClelland, Robyn L.
    Billheimer, Dean
    Reaven, Peter
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (08) : 1560 - 1571
  • [9] Microbiome and Cardiovascular Disease in CKD
    Jovanovich, Anna
    Isakova, Tamara
    Stubbs, Jason
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (10): : 1598 - 1604
  • [10] CARDIOVASCULAR RISK-FACTORS - INTERACTIVE EFFECTS OF LIPIDS, COAGULATION AND FIBRINOLYSIS
    DAAE, LNW
    KIERULF, P
    LANDAAS, S
    URDAL, P
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1993, 53 : 19 - 27
12345